Prime Medicine (PRME) Profit After Tax (2021 - 2025)
Historic Profit After Tax for Prime Medicine (PRME) over the last 5 years, with Q3 2025 value amounting to -$50.6 million.
- Prime Medicine's Profit After Tax rose 368.64% to -$50.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$197.3 million, marking a year-over-year increase of 999.32%. This contributed to the annual value of -$195.9 million for FY2024, which is 113.61% up from last year.
- According to the latest figures from Q3 2025, Prime Medicine's Profit After Tax is -$50.6 million, which was up 368.64% from -$52.6 million recorded in Q2 2025.
- Prime Medicine's Profit After Tax's 5-year high stood at -$16.4 million during Q3 2021, with a 5-year trough of -$65.6 million in Q4 2023.
- In the last 5 years, Prime Medicine's Profit After Tax had a median value of -$45.8 million in 2024 and averaged -$44.1 million.
- Data for Prime Medicine's Profit After Tax shows a peak YoY increase of 3755.78% (in 2022) and a maximum YoY decrease of 7883.26% (in 2022) over the last 5 years.
- Quarter analysis of 5 years shows Prime Medicine's Profit After Tax stood at -$62.9 million in 2021, then surged by 37.56% to -$39.3 million in 2022, then crashed by 67.1% to -$65.6 million in 2023, then surged by 35.6% to -$42.3 million in 2024, then dropped by 19.65% to -$50.6 million in 2025.
- Its Profit After Tax was -$50.6 million in Q3 2025, compared to -$52.6 million in Q2 2025 and -$51.9 million in Q1 2025.